Latest news
United Therapeutics (UTHR) CEO sells 9,500 shares after option exercise - Stock TitanStock Titan · Fri, 07 Aug 2026 20:32:02 GMTMorgan Stanley Adjusts PT on United Therapeutics to $515 From $516, Maintains Equalweight Rating - MoomooMoomoo · Thu, 06 Aug 2026 22:25:51 GMTUnited Therapeutics (UTHR) counsel exercises options, sells 8,300 shares - Stock TitanStock Titan · Thu, 06 Aug 2026 20:36:21 GMTUnited Therapeutics Corp (UTHR) CEO sells 9,500 shares under 10b5-1 plan - Stock TitanStock Titan · Thu, 06 Aug 2026 20:35:05 GMTHow Investors May Respond To United Therapeutics (UTHR) EPS Strength And Ralinepag’s Phase 3 Milestone - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 20:09:59 GMTUnited Therapeutics' Q2 Tyvaso Miss Reflects Competition; IPF Outreach Set to Expand, Morgan Stanley Says - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 15:03:35 GMTUnited Therapeutics Q2 Earnings Beat Estimates, Revenues Miss Mark - Zacks Investment ResearchZacks Investment Research · Thu, 06 Aug 2026 12:22:26 GMTUnited Therapeutics (UTHR) Stock Still Looks Cheap With Strong Returns Priced In - simplywall.stsimplywall.st · Wed, 05 Aug 2026 22:44:47 GMT